Laboratory Robot Handles Infectious Disease

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE:BDX) today announced FDA clearance and immediate market launch of the BD Viper System™ for in vitro infectious disease molecular diagnostic testing.

The BD Viper System is a novel, patented approach to laboratory automation using an industrial class of robotics known as Selective Compliance Assembly Robot Arm (SCARA). This classification indicates that the robot is multi-jointed (4-axis), similar to the human arm.
Incubations, amplification and detection all occur on the BD Viper System, with repetitive pipetting labor delegated to the robot. The SCARA robotic approach delivers an extremely robust instrument by eliminating all pumps, syringes and reagent tubing, commonly thought of as the “Achilles’ heel” of traditional laboratory equipment regarding maintenance and reliability.
The high throughput of the BD Viper System also helps address the critical shortage of technologists in laboratories.


- News & Events - BD Diagnostics Announces FDA 510(k) clearance of the BD Viper™ System